Global Gastrointestinal Cancer Drug Market Research Report 2017

December 2017 | 107 pages | ID: G13838AEA1DEN
QYResearch

Abstracts

In this report, the global Gastrointestinal Cancer Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gastrointestinal Cancer Drug in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Gastrointestinal Cancer Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Celgene Corporation
• F. Hoffmann-La Roche Ltd.
• Eli Lilly and Company
• GlaxoSmithKline plc.
• Pfizer Inc.
• Sanofi
• Novartis AG.
• Bristol-Myers Squibb Company
• Amgen Limited & Amgen Ireland Limited
• Johnson & Johnson Private Limited

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Therapy
• Immunotherapy
• Chemotherapy
• Targeted Therapy
• Radiation Therapy
• Hormone Therapy
• Adjuvant Chemotherapy
• By Route of Administration
• Oral
• Injectable Therapy

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Radiology
• Oncology

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Gastrointestinal Cancer Drug Market Research Report 2017

1 GASTROINTESTINAL CANCER DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Gastrointestinal Cancer Drug
1.2 Gastrointestinal Cancer Drug Segment By Therapy
  1.2.1 Global Gastrointestinal Cancer Drug Production and CAGR (%) Comparison By Therapy (Product Category)(2012-2022)
  1.2.2 Global Gastrointestinal Cancer Drug Production Market Share By Therapy (Product Category) in 2016
  1.2.3 Immunotherapy
  1.2.4 Chemotherapy
  1.2.5 Targeted Therapy
  1.2.6 Radiation Therapy
  1.2.7 Hormone Therapy
  1.2.8 Adjuvant Chemotherapy
1.3 Gastrointestinal Cancer Drug Segment By Route of Administration
  1.3.1 Oral
  1.3.2 Injectable Therapy
1.4 Global Gastrointestinal Cancer Drug Segment by Application
  1.4.1 Gastrointestinal Cancer Drug Consumption (Sales) Comparison by Application (2012-2022)
  1.4.2 Radiology
  1.4.3 Oncology
1.5 Global Gastrointestinal Cancer Drug Market by Region (2012-2022)
  1.5.1 Global Gastrointestinal Cancer Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.5.2 North America Status and Prospect (2012-2022)
  1.5.3 Europe Status and Prospect (2012-2022)
  1.5.4 China Status and Prospect (2012-2022)
  1.5.5 Japan Status and Prospect (2012-2022)
  1.5.6 Southeast Asia Status and Prospect (2012-2022)
  1.5.7 India Status and Prospect (2012-2022)
1.6 Global Market Size (Value) of Gastrointestinal Cancer Drug (2012-2022)
  1.6.1 Global Gastrointestinal Cancer Drug Revenue Status and Outlook (2012-2022)
  1.6.2 Global Gastrointestinal Cancer Drug Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL GASTROINTESTINAL CANCER DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Gastrointestinal Cancer Drug Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Gastrointestinal Cancer Drug Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Gastrointestinal Cancer Drug Production and Share by Manufacturers (2012-2017)
2.2 Global Gastrointestinal Cancer Drug Revenue and Share by Manufacturers (2012-2017)
2.3 Global Gastrointestinal Cancer Drug Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Gastrointestinal Cancer Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Gastrointestinal Cancer Drug Market Competitive Situation and Trends
  2.5.1 Gastrointestinal Cancer Drug Market Concentration Rate
  2.5.2 Gastrointestinal Cancer Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL GASTROINTESTINAL CANCER DRUG CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Gastrointestinal Cancer Drug Capacity and Market Share by Region (2012-2017)
3.2 Global Gastrointestinal Cancer Drug Production and Market Share by Region (2012-2017)
3.3 Global Gastrointestinal Cancer Drug Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL GASTROINTESTINAL CANCER DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Gastrointestinal Cancer Drug Consumption by Region (2012-2017)
4.2 North America Gastrointestinal Cancer Drug Production, Consumption, Export, Import (2012-2017)
4.3 Europe Gastrointestinal Cancer Drug Production, Consumption, Export, Import (2012-2017)
4.4 China Gastrointestinal Cancer Drug Production, Consumption, Export, Import (2012-2017)
4.5 Japan Gastrointestinal Cancer Drug Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Gastrointestinal Cancer Drug Production, Consumption, Export, Import (2012-2017)
4.7 India Gastrointestinal Cancer Drug Production, Consumption, Export, Import (2012-2017)

5 GLOBAL GASTROINTESTINAL CANCER DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Gastrointestinal Cancer Drug Production and Market Share by Type (2012-2017)
5.2 Global Gastrointestinal Cancer Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Gastrointestinal Cancer Drug Price by Type (2012-2017)
5.4 Global Gastrointestinal Cancer Drug Production Growth by Type (2012-2017)

6 GLOBAL GASTROINTESTINAL CANCER DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Gastrointestinal Cancer Drug Consumption and Market Share by Application (2012-2017)
6.2 Global Gastrointestinal Cancer Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL GASTROINTESTINAL CANCER DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Celgene Corporation
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Celgene Corporation Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 F. Hoffmann-La Roche Ltd.
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Eli Lilly and Company
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Eli Lilly and Company Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline plc.
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 GlaxoSmithKline plc. Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Pfizer Inc.
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Pfizer Inc. Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Sanofi
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Sanofi Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Novartis AG.
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Novartis AG. Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Bristol-Myers Squibb Company
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Amgen Limited & Amgen Ireland Limited
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Johnson & Johnson Private Limited
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview

8 GASTROINTESTINAL CANCER DRUG MANUFACTURING COST ANALYSIS

8.1 Gastrointestinal Cancer Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Gastrointestinal Cancer Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Gastrointestinal Cancer Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Gastrointestinal Cancer Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL GASTROINTESTINAL CANCER DRUG MARKET FORECAST (2017-2022)

12.1 Global Gastrointestinal Cancer Drug Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Gastrointestinal Cancer Drug Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Gastrointestinal Cancer Drug Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Gastrointestinal Cancer Drug Price and Trend Forecast (2017-2022)
12.2 Global Gastrointestinal Cancer Drug Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Gastrointestinal Cancer Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Gastrointestinal Cancer Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Gastrointestinal Cancer Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Gastrointestinal Cancer Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Gastrointestinal Cancer Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Gastrointestinal Cancer Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Gastrointestinal Cancer Drug Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Gastrointestinal Cancer Drug Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Gastrointestinal Cancer Drug
Figure Global Gastrointestinal Cancer Drug Production (MT) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Gastrointestinal Cancer Drug Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Immunotherapy
Table Major Manufacturers of Immunotherapy
Figure Product Picture of Chemotherapy
Table Major Manufacturers of Chemotherapy
Figure Product Picture of Targeted Therapy
Table Major Manufacturers of Targeted Therapy
Figure Product Picture of Radiation Therapy
Table Major Manufacturers of Radiation Therapy
Figure Product Picture of Hormone Therapy
Table Major Manufacturers of Hormone Therapy
Figure Product Picture of Adjuvant Chemotherapy
Table Major Manufacturers of Adjuvant Chemotherapy
Figure Global Gastrointestinal Cancer Drug Consumption (MT) by Applications (2012-2022)
Figure Global Gastrointestinal Cancer Drug Consumption Market Share by Applications in 2016
Figure Radiology Examples
Table Key Downstream Customer in Radiology
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Global Gastrointestinal Cancer Drug Market Size (Million USD), Comparison (MT) and CAGR (%) by Regions (2012-2022)
Figure North America Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Gastrointestinal Cancer Drug Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Gastrointestinal Cancer Drug Capacity, Production (MT) Status and Outlook (2012-2022)
Figure Global Gastrointestinal Cancer Drug Major Players Product Capacity (MT) (2012-2017)
Table Global Gastrointestinal Cancer Drug Capacity (MT) of Key Manufacturers (2012-2017)
Table Global Gastrointestinal Cancer Drug Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Gastrointestinal Cancer Drug Capacity (MT) of Key Manufacturers in 2016
Figure Global Gastrointestinal Cancer Drug Capacity (MT) of Key Manufacturers in 2017
Figure Global Gastrointestinal Cancer Drug Major Players Product Production (MT) (2012-2017)
Table Global Gastrointestinal Cancer Drug Production (MT) of Key Manufacturers (2012-2017)
Table Global Gastrointestinal Cancer Drug Production Share by Manufacturers (2012-2017)
Figure 2016 Gastrointestinal Cancer Drug Production Share by Manufacturers
Figure 2017 Gastrointestinal Cancer Drug Production Share by Manufacturers
Figure Global Gastrointestinal Cancer Drug Major Players Product Revenue (Million USD) (2012-2017)
Table Global Gastrointestinal Cancer Drug Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Gastrointestinal Cancer Drug Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Gastrointestinal Cancer Drug Revenue Share by Manufacturers
Table 2017 Global Gastrointestinal Cancer Drug Revenue Share by Manufacturers
Table Global Market Gastrointestinal Cancer Drug Average Price (USD/Kg) of Key Manufacturers (2012-2017)
Figure Global Market Gastrointestinal Cancer Drug Average Price (USD/Kg) of Key Manufacturers in 2016
Table Manufacturers Gastrointestinal Cancer Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Gastrointestinal Cancer Drug Product Category
Figure Gastrointestinal Cancer Drug Market Share of Top 3 Manufacturers
Figure Gastrointestinal Cancer Drug Market Share of Top 5 Manufacturers
Table Global Gastrointestinal Cancer Drug Capacity (MT) by Region (2012-2017)
Figure Global Gastrointestinal Cancer Drug Capacity Market Share by Region (2012-2017)
Figure Global Gastrointestinal Cancer Drug Capacity Market Share by Region (2012-2017)
Figure 2016 Global Gastrointestinal Cancer Drug Capacity Market Share by Region
Table Global Gastrointestinal Cancer Drug Production by Region (2012-2017)
Figure Global Gastrointestinal Cancer Drug Production (MT) by Region (2012-2017)
Figure Global Gastrointestinal Cancer Drug Production Market Share by Region (2012-2017)
Figure 2016 Global Gastrointestinal Cancer Drug Production Market Share by Region
Table Global Gastrointestinal Cancer Drug Revenue (Million USD) by Region (2012-2017)
Table Global Gastrointestinal Cancer Drug Revenue Market Share by Region (2012-2017)
Figure Global Gastrointestinal Cancer Drug Revenue Market Share by Region (2012-2017)
Table 2016 Global Gastrointestinal Cancer Drug Revenue Market Share by Region
Figure Global Gastrointestinal Cancer Drug Capacity, Production (MT) and Growth Rate (2012-2017)
Table Global Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table North America Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Europe Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table China Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Japan Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Southeast Asia Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table India Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Table Global Gastrointestinal Cancer Drug Consumption (MT) Market by Region (2012-2017)
Table Global Gastrointestinal Cancer Drug Consumption Market Share by Region (2012-2017)
Figure Global Gastrointestinal Cancer Drug Consumption Market Share by Region (2012-2017)
Figure 2016 Global Gastrointestinal Cancer Drug Consumption (MT) Market Share by Region
Table North America Gastrointestinal Cancer Drug Production, Consumption, Import & Export (MT) (2012-2017)
Table Europe Gastrointestinal Cancer Drug Production, Consumption, Import & Export (MT) (2012-2017)
Table China Gastrointestinal Cancer Drug Production, Consumption, Import & Export (MT) (2012-2017)
Table Japan Gastrointestinal Cancer Drug Production, Consumption, Import & Export (MT) (2012-2017)
Table Southeast Asia Gastrointestinal Cancer Drug Production, Consumption, Import & Export (MT) (2012-2017)
Table India Gastrointestinal Cancer Drug Production, Consumption, Import & Export (MT) (2012-2017)
Table Global Gastrointestinal Cancer Drug Production (MT) by Type (2012-2017)
Table Global Gastrointestinal Cancer Drug Production Share by Type (2012-2017)
Figure Production Market Share of Gastrointestinal Cancer Drug by Type (2012-2017)
Figure 2016 Production Market Share of Gastrointestinal Cancer Drug by Type
Table Global Gastrointestinal Cancer Drug Revenue (Million USD) by Type (2012-2017)
Table Global Gastrointestinal Cancer Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Gastrointestinal Cancer Drug by Type (2012-2017)
Figure 2016 Revenue Market Share of Gastrointestinal Cancer Drug by Type
Table Global Gastrointestinal Cancer Drug Price (USD/Kg) by Type (2012-2017)
Figure Global Gastrointestinal Cancer Drug Production Growth by Type (2012-2017)
Table Global Gastrointestinal Cancer Drug Consumption (MT) by Application (2012-2017)
Table Global Gastrointestinal Cancer Drug Consumption Market Share by Application (2012-2017)
Figure Global Gastrointestinal Cancer Drug Consumption Market Share by Applications (2012-2017)
Figure Global Gastrointestinal Cancer Drug Consumption Market Share by Application in 2016
Table Global Gastrointestinal Cancer Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Gastrointestinal Cancer Drug Consumption Growth Rate by Application (2012-2017)
Table Celgene Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Corporation Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Production Growth Rate (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Production Market Share (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Revenue Market Share (2012-2017)
Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Production Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Production Market Share (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Revenue Market Share (2012-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Production Growth Rate (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Production Market Share (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Revenue Market Share (2012-2017)
Table GlaxoSmithKline plc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline plc. Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Production Growth Rate (2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Production Market Share (2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Revenue Market Share (2012-2017)
Table Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc. Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Production Growth Rate (2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Production Market Share (2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Production Growth Rate (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Production Market Share (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Revenue Market Share (2012-2017)
Table Novartis AG. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG. Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Production Growth Rate (2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Production Market Share (2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Revenue Market Share (2012-2017)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Production Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Production Market Share (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Revenue Market Share (2012-2017)
Table Amgen Limited & Amgen Ireland Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Production Growth Rate (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Production Market Share (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Revenue Market Share (2012-2017)
Table Johnson & Johnson Private Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Capacity, Production (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Production Growth Rate (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Production Market Share (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal Cancer Drug
Figure Manufacturing Process Analysis of Gastrointestinal Cancer Drug
Figure Gastrointestinal Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal Cancer Drug Major Manufacturers in 2016
Table Major Buyers of Gastrointestinal Cancer Drug
Table Distributors/Traders List
Figure Global Gastrointestinal Cancer Drug Capacity, Production (MT) and Growth Rate Forecast (2017-2022)
Figure Global Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Gastrointestinal Cancer Drug Price (Million USD) and Trend Forecast (2017-2022)
Table Global Gastrointestinal Cancer Drug Production (MT) Forecast by Region (2017-2022)
Figure Global Gastrointestinal Cancer Drug Production Market Share Forecast by Region (2017-2022)
Table Global Gastrointestinal Cancer Drug Consumption (MT) Forecast by Region (2017-2022)
Figure Global Gastrointestinal Cancer Drug Consumption Market Share Forecast by Region (2017-2022)
Figure North America Gastrointestinal Cancer Drug Production (MT) and Growth Rate Forecast (2017-2022)
Figure North America Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Gastrointestinal Cancer Drug Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Europe Gastrointestinal Cancer Drug Production (MT) and Growth Rate Forecast (2017-2022)
Figure Europe Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Gastrointestinal Cancer Drug Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure China Gastrointestinal Cancer Drug Production (MT) and Growth Rate Forecast (2017-2022)
Figure China Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Gastrointestinal Cancer Drug Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Japan Gastrointestinal Cancer Drug Production (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Gastrointestinal Cancer Drug Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Southeast Asia Gastrointestinal Cancer Drug Production (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Gastrointestinal Cancer Drug Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure India Gastrointestinal Cancer Drug Production (MT) and Growth Rate Forecast (2017-2022)
Figure India Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Gastrointestinal Cancer Drug Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Table Global Gastrointestinal Cancer Drug Production (MT) Forecast by Type (2017-2022)
Figure Global Gastrointestinal Cancer Drug Production (MT) Forecast by Type (2017-2022)
Table Global Gastrointestinal Cancer Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Gastrointestinal Cancer Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Gastrointestinal Cancer Drug Price Forecast by Type (2017-2022)
Table Global Gastrointestinal Cancer Drug Consumption (MT) Forecast by Application (2017-2022)
Figure Global Gastrointestinal Cancer Drug Consumption (MT) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source